Use of SGLT-2 Inhibitors in Patients with Advanced Renal Disease
Use of SGLT-2 Inhibitors in Patients with Advanced Renal Disease
Speaker: Thomas Mavrakanas, MD, MSc, FRCPC, FASN
Associate Professor of Medicine, Â鶹´«Ã½ÍøÕ¾
Attending Physician, Division of Nephrology, Department of Medicine, Â鶹´«Ã½ÍøÕ¾ Health Centre
Scientist, Research Institute, Â鶹´«Ã½ÍøÕ¾ Health Centre
Member, Graduate Program in Clinical and Translational Research, Â鶹´«Ã½ÍøÕ¾
Director, Cardiorenal and Nephrology Research Fellowships, Â鶹´«Ã½ÍøÕ¾
Educational Objectives:
- Clinical evidence with SGLT-2 inhibitors in patients with moderate and advanced CKD
- Â Pharmacokinetics of SGLT-2 inhibitors in hemodialysis
- Clinical trials with SGLT-2 inhibitors in patients with end-stage renal disease
Join the Medical Grand Rounds on .
Or call in (audio only) NEW: +1 438-799-0762, 502095193# Canada, Montreal, Phone Conference ID: 502 095 193#
The Medical Grand Rounds are an accredited group learning activity as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada.
Some Rounds were .